ACADIA Pharmaceuticals, Inc. (ACAD)
19.95
+0.06
(+0.30%)
USD |
NASDAQ |
Oct 02, 16:00
19.96
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 3.434B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.434B |
| October 01, 2026 | 3.424B |
| September 30, 2026 | 3.468B |
| September 29, 2026 | 3.481B |
| September 28, 2026 | 3.534B |
| September 25, 2026 | 3.560B |
| September 24, 2026 | 3.818B |
| September 23, 2026 | 4.377B |
| September 22, 2026 | 4.546B |
| September 21, 2026 | 4.543B |
| September 18, 2026 | 4.697B |
| September 17, 2026 | 4.725B |
| September 16, 2026 | 4.741B |
| September 15, 2026 | 4.606B |
| September 14, 2026 | 4.737B |
| September 11, 2026 | 4.790B |
| September 10, 2026 | 4.775B |
| September 09, 2026 | 4.765B |
| September 08, 2026 | 4.747B |
| September 04, 2026 | 4.823B |
| September 03, 2026 | 4.796B |
| September 02, 2026 | 4.980B |
| September 01, 2026 | 4.973B |
| August 31, 2026 | 4.976B |
| August 28, 2026 | 5.011B |
| Date | Value |
|---|---|
| August 27, 2026 | 5.117B |
| August 26, 2026 | 5.092B |
| August 25, 2026 | 5.262B |
| August 24, 2026 | 5.104B |
| August 21, 2026 | 5.078B |
| August 20, 2026 | 4.999B |
| August 19, 2026 | 5.200B |
| August 18, 2026 | 5.195B |
| August 17, 2026 | 4.994B |
| August 14, 2026 | 4.861B |
| August 13, 2026 | 4.885B |
| August 12, 2026 | 5.069B |
| August 11, 2026 | 5.062B |
| August 10, 2026 | 5.059B |
| August 07, 2026 | 5.028B |
| August 06, 2026 | 4.897B |
| August 05, 2026 | 4.957B |
| August 04, 2026 | 4.673B |
| August 03, 2026 | 4.408B |
| July 31, 2026 | 4.426B |
| July 30, 2026 | 4.542B |
| July 29, 2026 | 4.506B |
| July 28, 2026 | 4.450B |
| July 27, 2026 | 4.344B |
| July 24, 2026 | 4.250B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.895B |
| Biogen, Inc. | 32.48B |
| Insmed, Inc. | 24.26B |
| Arcutis Biotherapeutics, Inc. | 3.160B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
Market Cap Related Metrics
| PE Ratio | 8.985 |
| PS Ratio | 3.012 |
| PEG Ratio | 0.1344 |
| Price to Book Value | 2.628 |
| Price to Free Cash Flow | 23.55 |
| Price | 19.95 |
| Earnings Yield | 11.13% |
| PEGY Ratio | 0.1344 |
| Operating PE Ratio | 39.71 |
| Normalized PE Ratio | 8.985 |